Clinical Trial Update: A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

View source ↗

Summary

Pfizer-sponsored real-world study evaluating Ritlecitinib in adults with severe alopecia areata has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Pfizer | Conditions: Severe Alopecia Areata | Status: COMPLETED